Skip to content

The efficacy of cefazolin in reducing surgical site infection in laparoscopic cholecystectomy

The efficacy of cefazolin in reducing surgical site infection in laparoscopic cholecystectomy

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20140224003
Enrollment
Unknown
Registered
2014-02-24
Start date
2009-08-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

laparoscopic cholecystectomy prophylactic antibiotics laparoscopic cholecystectomy cefazolin surgical site infection

Interventions

preoperative 1 gm diluted in 10 mL isotonic sodium chloride solution iv.,preoperative 10 ml iv
Active Comparator Drug,Placebo Comparator No treatment
cefazolin,Isotonic sodium chloride

Sponsors

Faculty of Medicine, Prince of Songkla University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to No maximum

Inclusion criteria

Inclusion criteria: All laparoscopic cholecystectomy patients at Songklanagarind Hospital

Exclusion criteria

Exclusion criteria: 1. Patients with current complicated gallstones: acute cholecystitis, symptomatic choledocholithiasis, intrahepatic duct stones, or acute gallstone pancreatitis, patients had history above can be enrollment if they completed recovery from conditions and clinical no symptoms. 2. History of cephalosporin or beta-lactam allergy, sensitivity, or anaphylaxis 3. History of antibiotic use within 7 days before laparoscopic cholecystectomy 4. History of biliary tract surgery, or prosthetic heart valve 5. Other infections such as urinary tract infection 6. Emergency cholecystectomy 7. Pediatric patient (age under 14 years old) 8. Single port procedure

Design outcomes

Primary

MeasureTime frame
surgical site infection at least 30 days after surgery definition of the CDC

Secondary

MeasureTime frame
No secondary outcome no no

Countries

ä·Â

Contacts

Public ContactSakchai Ruangsin

Faculty of Medicine

rsakchai@medicine.psu.ac.th66818540290

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026